Bandingkan Harga & Kinerja Charlie Hospital Semarang Tbk. (RSCH) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Charlie Hospital Semarang Tbk. dan Organon Pharma Indonesia Tbk.: Charlie Hospital Semarang Tbk. diperdagangkan di Rp430 (kapitalisasi pasar 1,11 T, volume 24 jam 25,61 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 10,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RSCH | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,11 T | 104,4 M |
Volume | 25,61 jt | — |
Lot | 256,07 rb | — |
Perputaran | 10,76 M | — |
Harga Rata-rata | 420,16 | — |
Nilai Transaksi | 10,76 M | — |
Harga Ekuilibrium Indikatif | 430 | — |
Volume Ekuilibrium Indikatif | 1,46 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Selengkapnya di halaman RSCH →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
